Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eicosanoids and renal vascular function in diseases.

John D Imig1

  • 1Vascular Biology Center, Department of Physiology, Medical College of Georgia, Augusta, GA 30912, USA. jdimig@mcg.edu

Clinical Science (London, England : 1979)
|June 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal hemodynamics underlie hepatorenal physiology in bile duct-ligated rats.

Clinical science (London, England : 1979)·2026
Same author

Editorial: New insights on vascular and metabolic diabetic complications.

Frontiers in physiology·2026
Same author

Renoprotective approaches against anthracycline nephrotoxicity.

Biochemical pharmacology·2026
Same author

NF Erythroid 2-Related Factor 2 Peroxisome Proliferator-Activated Receptor-γ Crosstalk: Reprogramming Monocytic Myeloid-Derived Suppressor Cells in Kidney Disease.

Kidney360·2025
Same author

EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage.

Biomolecules·2025
Same author

Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice.

European journal of pharmacology·2025

Arachidonic acid metabolites regulate kidney blood flow. Imbalances in these compounds, processed by COX, CYP450, and LOX pathways, can lead to kidney disease, but offer therapeutic targets.

Area of Science:

  • Nephrology
  • Renal Physiology
  • Biochemistry

Background:

  • Arachidonic acid metabolites are crucial for regulating renal hemodynamics.
  • Dysregulation of these metabolites contributes to renal vascular injury and end-stage renal disease.
  • Key pathways include cyclooxygenase (COX), cytochrome P450 (CYP450), and lipoxygenase (LOX).

Purpose of the Study:

  • To review the role of renal vascular eicosanoids in nephropathy pathogenesis.
  • To highlight therapeutic targets for renal diseases linked to hypertension, diabetes, metabolic syndrome, and acute renal failure.

Main Methods:

  • Literature review of experimental evidence.
  • Analysis of the impact of altered eicosanoid metabolism in pathophysiological conditions.
  • Examination of potential therapeutic interventions.

Related Experiment Videos

Main Results:

  • Eicosanoids derived from arachidonic acid significantly influence renal vascular tone.
  • Altered eicosanoid generation is observed in hypertension, diabetes, metabolic syndrome, and acute renal failure.
  • Experimental data link aberrant eicosanoid metabolism to renal hemodynamic changes and nephropathy progression.

Conclusions:

  • Renal vascular eicosanoids play a critical role in the development and progression of nephropathy.
  • Enzymatic inhibitors, eicosanoid analogues, and receptor antagonists show promise as therapeutic strategies.
  • Targeting eicosanoid pathways offers potential for managing renal complications in various diseases.